AC Immune SA (ACIU)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Andrea Pfeifer
Employees:
140
EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, SWITZERLAND 00000
41 21 345 91 21

AC Immune SA discovers, designs, and develops medicines and diagnostic products. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease. It is also developing ACI-24, an anti-Abeta vaccine candidate, as well as completed Phase Ib clinical study for Down syndrome. Further, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases.

Data derived from most recent annual or quarterly report
Market Cap 203.032 Million Shares Outstanding83.552 Million Avg 30-day Volume 228.196 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.97
Price to Revenue21.345 Debt to Equity0.0083 EBITDA-67.577 Million
Price to Book Value1.5286 Operating Margin-396.99309999999997 Enterprise Value118.857 Million
Current Ratio16.534 EPS Growth-2.344 Quick Ratio16.138
1 Yr BETA 1.2433 52-week High/Low 4.93 / 1.68 Profit Margin-401.2767
Operating Cash Flow Growth-217.7051 Altman Z-Score8.8003 Free Cash Flow to Firm -52.357 Million
Earnings Report2023-03-22
View SEC Filings from ACIU instead.

AC Immune SA YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ACIU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACIU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AC IMMUNE SA ACIU 2023-02-03 22:15:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 21:45:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 21:15:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 20:45:06 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 20:15:04 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 19:45:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 19:15:04 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 18:45:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 18:15:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 17:45:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 17:15:04 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 16:45:04 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 16:15:03 UTC 0.5679 4.0021 90000
AC IMMUNE SA ACIU 2023-02-03 15:45:03 UTC 0.5679 4.0021 55000
AC IMMUNE SA ACIU 2023-02-03 15:15:03 UTC 0.5679 4.0021 55000
AC IMMUNE SA ACIU 2023-02-03 14:45:04 UTC 1.4754 2.8446 50000
AC IMMUNE SA ACIU 2023-02-03 14:15:04 UTC 1.4754 2.8446 50000
AC IMMUNE SA ACIU 2023-02-03 13:45:03 UTC 1.4754 2.8446 50000
AC IMMUNE SA ACIU 2023-02-03 13:15:03 UTC 1.4754 2.8446 50000
AC IMMUNE SA ACIU 2023-02-03 12:45:03 UTC 1.4754 2.8446 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ACIU -600.0 shares, $-1896.0 2022-09-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments